Assessment of the risk/benefit ratio of phase II cancer clinical trials by Institutional Review Board (IRB) members (Q34786291)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Assessment of the risk/benefit ratio of phase II cancer clinical trials by Institutional Review Board (IRB) members |
scientific article |
Statements
1 reference
Assessment of the risk/benefit ratio of phase II cancer clinical trials by Institutional Review Board (IRB) members (English)
1 reference
H E M Van Luijn
1 reference
A W Musschenga
1 reference
R B Keus
1 reference
W M Robinson
1 reference
N K Aaronson
1 reference
1 August 2002
1 reference
1 reference
13
1 reference
8
1 reference
1307-1313
1 reference
Identifiers
1 reference
1 reference